NCT01591629View on ClinicalTrials.gov

The Effects of ∆-9-THC and Naloxone in Humans

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 4, 2011

Primary Completion Date

June 1, 2012

Study Completion Date

June 1, 2012

Conditions
Healthy
Interventions
DRUG

Naloxone

Active Naloxone 18 mcg/kg intravenously over 60 minutes, 2mg IV push, 1mg IV push

DRUG

Delta-9-THC

Active Delta-9-THC (0.025mg/Kg) given intravenously over 20 minutes.

DRUG

Placebo

Placebo

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT01591629 - The Effects of ∆-9-THC and Naloxone in Humans | Biotech Hunter | Biotech Hunter